4 news items
Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affairs
CRNX
30 May 24
the treatment landscape and offer new, innovative options." Prior to joining Crinetics, Dr. Cuddihy served as section chief, endocrinology, diabetes
Crinetics Pharmaceuticals To Present Advancements From Atumelnant And Paltusotine Development Programs At ENDO 2024 June 1-4, 2024
CRNX
8 May 24
and Innovation Theater led by Dr. Kevin C.J. Yuen, of the Barrow Neurological Institute, on Saturday, June 1, 2024, titled "Paltusotine: A Novel
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
ACMR
AFIB
ALHC
19 Mar 24
) fell 5.8% to $7.76. The company launched an innovative in-vehicle voice assistant today.
Bitdeer Technologies Group
Crinetics' Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-2 Study in Acromegaly Patients
CRNX
19 Mar 24
treatment. If approved, the prospect that paltusotine can offer an innovative, once-daily oral alternative represents a significant step forward
- Prev
- 1
- Next